04 . 12 .2025
Press release
Galderma secures ‘BBB’ credit rating with positive outlook from S&P Global Ratings
17 . 11 .2025
Press release
ASDS 2025: Compelling new data on Restylane, Sculptra and Relfydess highlight Galderma’s innovative Injectable Aesthetics portfolio and pipeline
05 . 11 .2025
Press release
Galderma receives U.S. FDA approval for Restylane® Lyft™ for the enhancement of the chin profile
29 . 10 .2025
News story
Two patients, one condition: the overlooked impact of atopic dermatitis on families
23 . 10 .2025
Press release
Galderma delivers record net sales of 3.737 billion USD in the first nine months of 2025 and 15.0% year-on-year growth at constant currency, raises full-year guidance
24 . 09 .2025
Press release
AMWC Dubai: Galderma demonstrates Injectable Aesthetics leadership through updates on its scientific innovations and community education
18 . 09 .2025
Press release
Galderma launches transformative skincare segment with Cetaphil’s new Skin Activator Hydrating & Firming Line, in partnership with actor and filmmaker Mariska Hargitay